

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 7.35227815 |
| 2 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 6.86103354 |
| 3 | regulation of actin filament-based movement (GO:1903115) | 6.08914264 |
| 4 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.05755060 |
| 5 | cell communication involved in cardiac conduction (GO:0086065) | 6.02189288 |
| 6 | cardiac muscle contraction (GO:0060048) | 5.95591266 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.82249960 |
| 8 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.69630376 |
| 9 | cardiac myofibril assembly (GO:0055003) | 5.67863363 |
| 10 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.57498870 |
| 11 | sarcomere organization (GO:0045214) | 5.51025449 |
| 12 | regulation of cardiac muscle cell contraction (GO:0086004) | 5.40359825 |
| 13 | cardiac muscle hypertrophy (GO:0003300) | 5.10213221 |
| 14 | myofibril assembly (GO:0030239) | 5.08607753 |
| 15 | synaptic vesicle maturation (GO:0016188) | 5.07362966 |
| 16 | locomotory exploration behavior (GO:0035641) | 5.05604159 |
| 17 | regulation of relaxation of muscle (GO:1901077) | 4.98077393 |
| 18 | regulation of cell communication by electrical coupling (GO:0010649) | 4.89875713 |
| 19 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.85699832 |
| 20 | regulation of the force of heart contraction (GO:0002026) | 4.81218245 |
| 21 | striated muscle hypertrophy (GO:0014897) | 4.80623294 |
| 22 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.75994436 |
| 23 | synaptic vesicle exocytosis (GO:0016079) | 4.73470873 |
| 24 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.58644404 |
| 25 | relaxation of cardiac muscle (GO:0055119) | 4.54241162 |
| 26 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.43353757 |
| 27 | glutamate secretion (GO:0014047) | 4.40634999 |
| 28 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.38468238 |
| 29 | cardiac chamber formation (GO:0003207) | 4.35208714 |
| 30 | vocalization behavior (GO:0071625) | 4.35053888 |
| 31 | response to pheromone (GO:0019236) | 4.34002534 |
| 32 | actin-myosin filament sliding (GO:0033275) | 4.31517746 |
| 33 | muscle filament sliding (GO:0030049) | 4.31517746 |
| 34 | neuronal action potential propagation (GO:0019227) | 4.27988485 |
| 35 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.26987070 |
| 36 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.24221166 |
| 37 | regulation of synaptic vesicle transport (GO:1902803) | 4.24033150 |
| 38 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.22976996 |
| 39 | striated muscle contraction (GO:0006941) | 4.22947543 |
| 40 | muscle hypertrophy (GO:0014896) | 4.22317697 |
| 41 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.14368383 |
| 42 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.12261750 |
| 43 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.10908225 |
| 44 | regulation of heart rate (GO:0002027) | 4.10713057 |
| 45 | synaptic transmission, glutamatergic (GO:0035249) | 4.08215472 |
| 46 | cardiac conduction (GO:0061337) | 4.07646674 |
| 47 | regulation of membrane repolarization (GO:0060306) | 4.06225023 |
| 48 | regulation of striated muscle contraction (GO:0006942) | 4.05699174 |
| 49 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 4.03255566 |
| 50 | cardiac muscle cell development (GO:0055013) | 4.01844084 |
| 51 | cellular potassium ion homeostasis (GO:0030007) | 4.01300195 |
| 52 | neurotransmitter secretion (GO:0007269) | 4.01100944 |
| 53 | glutamate receptor signaling pathway (GO:0007215) | 4.00939601 |
| 54 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.00846057 |
| 55 | regulation of cardiac muscle contraction (GO:0055117) | 3.99420063 |
| 56 | adult heart development (GO:0007512) | 3.94642745 |
| 57 | cardiac ventricle formation (GO:0003211) | 3.94138287 |
| 58 | cardiac muscle cell action potential (GO:0086001) | 3.92624351 |
| 59 | detection of calcium ion (GO:0005513) | 3.92133181 |
| 60 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.90731382 |
| 61 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.83781679 |
| 62 | exploration behavior (GO:0035640) | 3.83191328 |
| 63 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.80887858 |
| 64 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.79018814 |
| 65 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.79004324 |
| 66 | regulation of cardioblast differentiation (GO:0051890) | 3.77495696 |
| 67 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.76384253 |
| 68 | neuron-neuron synaptic transmission (GO:0007270) | 3.73655564 |
| 69 | cardiac cell development (GO:0055006) | 3.73462494 |
| 70 | cerebellar granule cell differentiation (GO:0021707) | 3.72196630 |
| 71 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.72070417 |
| 72 | protein localization to synapse (GO:0035418) | 3.71288466 |
| 73 | positive regulation of synapse maturation (GO:0090129) | 3.69995204 |
| 74 | adrenergic receptor signaling pathway (GO:0071875) | 3.69092709 |
| 75 | actomyosin structure organization (GO:0031032) | 3.66919237 |
| 76 | long-term memory (GO:0007616) | 3.65812971 |
| 77 | cardiac muscle adaptation (GO:0014887) | 3.65462610 |
| 78 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.65462610 |
| 79 | muscle hypertrophy in response to stress (GO:0003299) | 3.65462610 |
| 80 | chemosensory behavior (GO:0007635) | 3.64707514 |
| 81 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.63425141 |
| 82 | neuron cell-cell adhesion (GO:0007158) | 3.62976579 |
| 83 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.59941010 |
| 84 | cellular response to epinephrine stimulus (GO:0071872) | 3.59416038 |
| 85 | gamma-aminobutyric acid transport (GO:0015812) | 3.59222577 |
| 86 | muscle tissue morphogenesis (GO:0060415) | 3.55736542 |
| 87 | actin-mediated cell contraction (GO:0070252) | 3.55642749 |
| 88 | sodium ion export (GO:0071436) | 3.54756656 |
| 89 | regulation of heart contraction (GO:0008016) | 3.53558703 |
| 90 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.52589504 |
| 91 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.52300881 |
| 92 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.51744521 |
| 93 | innervation (GO:0060384) | 3.51217931 |
| 94 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.46814690 |
| 95 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.46659296 |
| 96 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.46659296 |
| 97 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.44443400 |
| 98 | positive regulation of sodium ion transport (GO:0010765) | 3.43696219 |
| 99 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.43632214 |
| 100 | activation of protein kinase A activity (GO:0034199) | 3.43059831 |
| 101 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.42661897 |
| 102 | response to epinephrine (GO:0071871) | 3.42446491 |
| 103 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.40717336 |
| 104 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.36122564 |
| 105 | cellular sodium ion homeostasis (GO:0006883) | 3.36099926 |
| 106 | layer formation in cerebral cortex (GO:0021819) | 3.35214972 |
| 107 | cell communication by electrical coupling (GO:0010644) | 3.34082601 |
| 108 | synaptic vesicle endocytosis (GO:0048488) | 3.33716467 |
| 109 | insulin secretion (GO:0030073) | 3.30104673 |
| 110 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.28591997 |
| 111 | regulation of vesicle fusion (GO:0031338) | 3.27666792 |
| 112 | Golgi transport vesicle coating (GO:0048200) | 3.27545202 |
| 113 | COPI coating of Golgi vesicle (GO:0048205) | 3.27545202 |
| 114 | positive regulation of membrane potential (GO:0045838) | 3.27277541 |
| 115 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.27046262 |
| 116 | neurotransmitter transport (GO:0006836) | 3.25939953 |
| 117 | protein targeting to Golgi (GO:0000042) | 3.24629102 |
| 118 | positive regulation of action potential (GO:0045760) | 3.22132883 |
| 119 | cerebellar Purkinje cell layer development (GO:0021680) | 3.19942470 |
| 120 | regulation of postsynaptic membrane potential (GO:0060078) | 3.19319897 |
| 121 | regulation of ATP catabolic process (GO:1903289) | 3.14041030 |
| 122 | regulation of ATPase activity (GO:0043462) | 3.14041030 |
| 123 | regulation of neurotransmitter secretion (GO:0046928) | 3.13438246 |
| 124 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.12074130 |
| 125 | cell differentiation in hindbrain (GO:0021533) | 3.11880126 |
| 126 | membrane depolarization during action potential (GO:0086010) | 3.10930318 |
| 127 | dendritic spine morphogenesis (GO:0060997) | 3.10290857 |
| 128 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.10251883 |
| 129 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.10184475 |
| 130 | positive regulation of exocytosis (GO:0045921) | 3.09552132 |
| 131 | long-term synaptic potentiation (GO:0060291) | 3.08073217 |
| 132 | presynaptic membrane organization (GO:0097090) | 3.07082780 |
| 133 | regulation of ARF protein signal transduction (GO:0032012) | 3.05916432 |
| 134 | relaxation of muscle (GO:0090075) | 3.05487339 |
| 135 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.03176594 |
| 136 | multicellular organismal signaling (GO:0035637) | 3.00781399 |
| 137 | transmission of nerve impulse (GO:0019226) | 2.98939144 |
| 138 | neuromuscular process controlling posture (GO:0050884) | 2.98781490 |
| 139 | inner ear receptor cell development (GO:0060119) | 2.98403758 |
| 140 | vesicle transport along microtubule (GO:0047496) | 2.98200081 |
| 141 | positive regulation of heart rate (GO:0010460) | 2.97912886 |
| 142 | regulation of cation channel activity (GO:2001257) | 2.97813563 |
| 143 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.97346057 |
| 144 | potassium ion import (GO:0010107) | 2.96994937 |
| 145 | regulation of synaptic plasticity (GO:0048167) | 2.96221198 |
| 146 | neuron recognition (GO:0008038) | 2.95861424 |
| 147 | proline transport (GO:0015824) | 2.94206934 |
| 148 | establishment of protein localization to Golgi (GO:0072600) | 2.94097643 |
| 149 | regulation of sarcomere organization (GO:0060297) | 2.93869689 |
| 150 | dendrite morphogenesis (GO:0048813) | 2.92940156 |
| 151 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.92875355 |
| 152 | regulation of neurotransmitter levels (GO:0001505) | 2.92206127 |
| 153 | long term synaptic depression (GO:0060292) | 2.90948787 |
| 154 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.90167629 |
| 155 | regulation of exocytosis (GO:0017157) | 2.86983303 |
| 156 | positive regulation of vesicle fusion (GO:0031340) | 2.85739212 |
| 157 | positive regulation of cation channel activity (GO:2001259) | 2.85425890 |
| 158 | suckling behavior (GO:0001967) | 2.85330935 |
| 159 | regulation of synapse structural plasticity (GO:0051823) | 2.83584548 |
| 160 | membrane depolarization (GO:0051899) | 2.83189178 |
| 161 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.82862161 |
| 162 | signal release (GO:0023061) | 2.82491777 |
| 163 | potassium ion homeostasis (GO:0055075) | 2.82014017 |
| 164 | cellular response to catecholamine stimulus (GO:0071870) | 2.81201987 |
| 165 | calcium ion-dependent exocytosis (GO:0017156) | 2.80987004 |
| 166 | neuromuscular process controlling balance (GO:0050885) | 2.79801427 |
| 167 | postsynaptic membrane organization (GO:0001941) | 2.79779466 |
| 168 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.78830556 |
| 169 | synapse assembly (GO:0007416) | 2.78679601 |
| 170 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.78602160 |
| 171 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.78365889 |
| 172 | regulation of neurotransmitter transport (GO:0051588) | 2.78133129 |
| 173 | negative regulation of hormone metabolic process (GO:0032351) | 2.77602402 |
| 174 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.77602402 |
| 175 | membrane repolarization (GO:0086009) | 2.76564199 |
| 176 | membrane repolarization during action potential (GO:0086011) | 2.75414825 |
| 177 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.75262915 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.75238856 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.44426560 |
| 3 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.92859706 |
| 4 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.89979031 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.84056962 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.81243125 |
| 7 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.64521383 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.58258925 |
| 9 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.46930001 |
| 10 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.42853018 |
| 11 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.37001237 |
| 12 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.32155660 |
| 13 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.31567817 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.31522985 |
| 15 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.30707692 |
| 16 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.30707692 |
| 17 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.27264916 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.26517746 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.16719137 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.14822809 |
| 21 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.14742007 |
| 22 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.13439883 |
| 23 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.11209523 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.00307956 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.97644197 |
| 26 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.96537226 |
| 27 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.92329837 |
| 28 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.89391836 |
| 29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.84366530 |
| 30 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.77978682 |
| 31 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.74235208 |
| 32 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.71570283 |
| 33 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.70777206 |
| 34 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.64009472 |
| 35 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.58902907 |
| 36 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.58043230 |
| 37 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.55903724 |
| 38 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.55288990 |
| 39 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.51475453 |
| 40 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.46417623 |
| 41 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.46417623 |
| 42 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.46312474 |
| 43 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.45056405 |
| 44 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.41576081 |
| 45 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.38838532 |
| 46 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.38386593 |
| 47 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.36329020 |
| 48 | AR_19668381_ChIP-Seq_PC3_Human | 1.34315815 |
| 49 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.34249289 |
| 50 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.33983822 |
| 51 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.31555942 |
| 52 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.31325900 |
| 53 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.30516524 |
| 54 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.29686888 |
| 55 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28803621 |
| 56 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.27563750 |
| 57 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.26905989 |
| 58 | AR_25329375_ChIP-Seq_VCAP_Human | 1.26303071 |
| 59 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.24991468 |
| 60 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.24490819 |
| 61 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24362089 |
| 62 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.23483160 |
| 63 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.22578761 |
| 64 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.22291028 |
| 65 | VDR_22108803_ChIP-Seq_LS180_Human | 1.21798747 |
| 66 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.21433164 |
| 67 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.21052202 |
| 68 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.20614985 |
| 69 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.20188389 |
| 70 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.18340491 |
| 71 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.17938062 |
| 72 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.14499328 |
| 73 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.14385534 |
| 74 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.13987451 |
| 75 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.13623210 |
| 76 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.13373347 |
| 77 | TP53_16413492_ChIP-PET_HCT116_Human | 1.12014990 |
| 78 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.12008518 |
| 79 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.11706039 |
| 80 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.11429454 |
| 81 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08933282 |
| 82 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.08069060 |
| 83 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.07543363 |
| 84 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.07093848 |
| 85 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.06689416 |
| 86 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.06435494 |
| 87 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.06198815 |
| 88 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.04150442 |
| 89 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03058522 |
| 90 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02906048 |
| 91 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.02539872 |
| 92 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.00694742 |
| 93 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.00311842 |
| 94 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.99990574 |
| 95 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.99688862 |
| 96 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.99109257 |
| 97 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98222649 |
| 98 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.98085655 |
| 99 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.97965221 |
| 100 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.97167446 |
| 101 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.97143142 |
| 102 | KDM2B_26808549_Chip-Seq_K562_Human | 0.96692727 |
| 103 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.96603816 |
| 104 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.96008658 |
| 105 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95765519 |
| 106 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94678273 |
| 107 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.94071495 |
| 108 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.92431989 |
| 109 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.91907136 |
| 110 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.91715607 |
| 111 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.90369453 |
| 112 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90041744 |
| 113 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89739396 |
| 114 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.89109047 |
| 115 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89093741 |
| 116 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.88546798 |
| 117 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.88302698 |
| 118 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87473275 |
| 119 | GATA1_22025678_ChIP-Seq_K562_Human | 0.87411119 |
| 120 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.86964880 |
| 121 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.86917304 |
| 122 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.86525966 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.38380077 |
| 2 | MP0004084_abnormal_cardiac_muscle | 4.92132068 |
| 3 | MP0000751_myopathy | 4.05591937 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.68654489 |
| 5 | MP0004270_analgesia | 3.63996174 |
| 6 | MP0003880_abnormal_central_pattern | 3.46998009 |
| 7 | MP0009046_muscle_twitch | 3.01127415 |
| 8 | MP0009780_abnormal_chondrocyte_physiolo | 3.00351488 |
| 9 | MP0002909_abnormal_adrenal_gland | 2.97345662 |
| 10 | MP0002063_abnormal_learning/memory/cond | 2.82058201 |
| 11 | MP0009745_abnormal_behavioral_response | 2.81386557 |
| 12 | MP0002064_seizures | 2.68907453 |
| 13 | MP0008775_abnormal_heart_ventricle | 2.59876395 |
| 14 | MP0005330_cardiomyopathy | 2.59513086 |
| 15 | MP0002972_abnormal_cardiac_muscle | 2.59030382 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.49836527 |
| 17 | MP0002572_abnormal_emotion/affect_behav | 2.49266589 |
| 18 | MP0002272_abnormal_nervous_system | 2.48000473 |
| 19 | MP0001968_abnormal_touch/_nociception | 2.39967534 |
| 20 | MP0004484_altered_response_of | 2.38928820 |
| 21 | MP0005423_abnormal_somatic_nervous | 2.21768685 |
| 22 | MP0003283_abnormal_digestive_organ | 2.20848746 |
| 23 | MP0000749_muscle_degeneration | 2.15727165 |
| 24 | MP0000013_abnormal_adipose_tissue | 2.15422388 |
| 25 | MP0008569_lethality_at_weaning | 2.09896814 |
| 26 | MP0002735_abnormal_chemical_nociception | 2.07965267 |
| 27 | MP0004043_abnormal_pH_regulation | 2.05424724 |
| 28 | MP0001501_abnormal_sleep_pattern | 2.02941930 |
| 29 | MP0005620_abnormal_muscle_contractility | 2.00496526 |
| 30 | MP0001486_abnormal_startle_reflex | 1.97894556 |
| 31 | MP0004145_abnormal_muscle_electrophysio | 1.97734787 |
| 32 | MP0004087_abnormal_muscle_fiber | 1.93484484 |
| 33 | MP0002067_abnormal_sensory_capabilities | 1.91824222 |
| 34 | MP0001440_abnormal_grooming_behavior | 1.90831804 |
| 35 | MP0010386_abnormal_urinary_bladder | 1.88342659 |
| 36 | MP0002733_abnormal_thermal_nociception | 1.87205281 |
| 37 | MP0005385_cardiovascular_system_phenoty | 1.87087867 |
| 38 | MP0001544_abnormal_cardiovascular_syste | 1.87087867 |
| 39 | MP0010630_abnormal_cardiac_muscle | 1.81601828 |
| 40 | MP0002736_abnormal_nociception_after | 1.80539589 |
| 41 | MP0002877_abnormal_melanocyte_morpholog | 1.77072934 |
| 42 | MP0002184_abnormal_innervation | 1.76704507 |
| 43 | MP0006072_abnormal_retinal_apoptosis | 1.75304597 |
| 44 | MP0006138_congestive_heart_failure | 1.73414986 |
| 45 | MP0001970_abnormal_pain_threshold | 1.72246098 |
| 46 | MP0003329_amyloid_beta_deposits | 1.68658418 |
| 47 | MP0002837_dystrophic_cardiac_calcinosis | 1.65962755 |
| 48 | MP0005646_abnormal_pituitary_gland | 1.64662668 |
| 49 | MP0002693_abnormal_pancreas_physiology | 1.63088496 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.61554202 |
| 51 | MP0004130_abnormal_muscle_cell | 1.61447466 |
| 52 | MP0002557_abnormal_social/conspecific_i | 1.60723928 |
| 53 | MP0002106_abnormal_muscle_physiology | 1.59107643 |
| 54 | MP0005551_abnormal_eye_electrophysiolog | 1.56988319 |
| 55 | MP0003879_abnormal_hair_cell | 1.56702844 |
| 56 | MP0004924_abnormal_behavior | 1.54169716 |
| 57 | MP0005386_behavior/neurological_phenoty | 1.54169716 |
| 58 | MP0001502_abnormal_circadian_rhythm | 1.50843595 |
| 59 | MP0001944_abnormal_pancreas_morphology | 1.50676129 |
| 60 | MP0000955_abnormal_spinal_cord | 1.49797795 |
| 61 | MP0003787_abnormal_imprinting | 1.49765753 |
| 62 | MP0004811_abnormal_neuron_physiology | 1.47245856 |
| 63 | MP0005645_abnormal_hypothalamus_physiol | 1.46686484 |
| 64 | MP0002638_abnormal_pupillary_reflex | 1.44416476 |
| 65 | MP0002127_abnormal_cardiovascular_syste | 1.44205634 |
| 66 | MP0003122_maternal_imprinting | 1.40626187 |
| 67 | MP0000747_muscle_weakness | 1.39949428 |
| 68 | MP0001984_abnormal_olfaction | 1.36659879 |
| 69 | MP0000750_abnormal_muscle_regeneration | 1.35280887 |
| 70 | MP0003646_muscle_fatigue | 1.35178615 |
| 71 | MP0005670_abnormal_white_adipose | 1.34304478 |
| 72 | MP0005379_endocrine/exocrine_gland_phen | 1.33295732 |
| 73 | MP0000778_abnormal_nervous_system | 1.33169258 |
| 74 | MP0004885_abnormal_endolymph | 1.31506169 |
| 75 | MP0002882_abnormal_neuron_morphology | 1.31300951 |
| 76 | MP0003633_abnormal_nervous_system | 1.30990793 |
| 77 | MP0004858_abnormal_nervous_system | 1.29761573 |
| 78 | MP0005369_muscle_phenotype | 1.29397378 |
| 79 | MP0002269_muscular_atrophy | 1.29337280 |
| 80 | MP0002066_abnormal_motor_capabilities/c | 1.29010550 |
| 81 | MP0002229_neurodegeneration | 1.21344607 |
| 82 | MP0002234_abnormal_pharynx_morphology | 1.20580565 |
| 83 | MP0000678_abnormal_parathyroid_gland | 1.16527745 |
| 84 | MP0006276_abnormal_autonomic_nervous | 1.14124920 |
| 85 | MP0005253_abnormal_eye_physiology | 1.12611044 |
| 86 | MP0005165_increased_susceptibility_to | 1.12185445 |
| 87 | MP0003195_calcinosis | 1.06982141 |
| 88 | MP0003172_abnormal_lysosome_physiology | 1.06439764 |
| 89 | MP0008961_abnormal_basal_metabolism | 1.06252070 |
| 90 | MP0003631_nervous_system_phenotype | 1.05363441 |
| 91 | MP0005535_abnormal_body_temperature | 1.02751694 |
| 92 | MP0002078_abnormal_glucose_homeostasis | 1.02690920 |
| 93 | MP0004142_abnormal_muscle_tone | 1.00496241 |
| 94 | MP0000631_abnormal_neuroendocrine_gland | 0.99585582 |
| 95 | MP0000759_abnormal_skeletal_muscle | 0.99399187 |
| 96 | MP0002152_abnormal_brain_morphology | 0.96322124 |
| 97 | MP0002822_catalepsy | 0.96222809 |
| 98 | MP0010368_abnormal_lymphatic_system | 0.95770470 |
| 99 | MP0001188_hyperpigmentation | 0.94268619 |
| 100 | MP0002069_abnormal_eating/drinking_beha | 0.93731906 |
| 101 | MP0001765_abnormal_ion_homeostasis | 0.91968224 |
| 102 | MP0005187_abnormal_penis_morphology | 0.91745850 |
| 103 | MP0004215_abnormal_myocardial_fiber | 0.90614758 |
| 104 | MP0001986_abnormal_taste_sensitivity | 0.90404196 |
| 105 | MP0004085_abnormal_heartbeat | 0.90143728 |
| 106 | MP0000003_abnormal_adipose_tissue | 0.88874030 |
| 107 | MP0002332_abnormal_exercise_endurance | 0.86700638 |
| 108 | MP0003632_abnormal_nervous_system | 0.86460637 |
| 109 | MP0000920_abnormal_myelination | 0.85934684 |
| 110 | MP0003690_abnormal_glial_cell | 0.85774100 |
| 111 | MP0003634_abnormal_glial_cell | 0.83653198 |
| 112 | MP0002876_abnormal_thyroid_physiology | 0.82685162 |
| 113 | MP0001299_abnormal_eye_distance/ | 0.80566143 |
| 114 | MP0004233_abnormal_muscle_weight | 0.77810567 |
| 115 | MP0002090_abnormal_vision | 0.77472174 |
| 116 | MP0003953_abnormal_hormone_level | 0.76049902 |
| 117 | MP0004742_abnormal_vestibular_system | 0.74276728 |
| 118 | MP0004147_increased_porphyrin_level | 0.71710450 |
| 119 | MP0005623_abnormal_meninges_morphology | 0.70207648 |
| 120 | MP0003045_fibrosis | 0.69807411 |
| 121 | MP0001348_abnormal_lacrimal_gland | 0.68833488 |
| 122 | MP0001963_abnormal_hearing_physiology | 0.68776192 |
| 123 | MP0005409_darkened_coat_color | 0.68284543 |
| 124 | MP0000569_abnormal_digit_pigmentation | 0.66385552 |
| 125 | MP0000266_abnormal_heart_morphology | 0.66244788 |
| 126 | MP0002752_abnormal_somatic_nervous | 0.64588216 |
| 127 | MP0004510_myositis | 0.64190987 |
| 128 | MP0003123_paternal_imprinting | 0.63968013 |
| 129 | MP0004036_abnormal_muscle_relaxation | 0.63885422 |
| 130 | MP0003567_abnormal_fetal_cardiomyocyte | 0.63272649 |
| 131 | MP0003279_aneurysm | 0.61788751 |
| 132 | MP0000604_amyloidosis | 0.61008706 |
| 133 | MP0001905_abnormal_dopamine_level | 0.60906537 |
| 134 | MP0001529_abnormal_vocalization | 0.59573215 |
| 135 | MP0006292_abnormal_olfactory_placode | 0.59256495 |
| 136 | MP0003137_abnormal_impulse_conducting | 0.56604295 |
| 137 | MP0002896_abnormal_bone_mineralization | 0.55374366 |
| 138 | MP0003828_pulmonary_edema | 0.54290539 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 8.62058060 |
| 2 | Atrial fibrillation (HP:0005110) | 6.74598343 |
| 3 | Syncope (HP:0001279) | 6.57833045 |
| 4 | Ventricular tachycardia (HP:0004756) | 6.25630632 |
| 5 | Primary atrial arrhythmia (HP:0001692) | 6.19621815 |
| 6 | Focal motor seizures (HP:0011153) | 5.96200867 |
| 7 | Supraventricular tachycardia (HP:0004755) | 5.95718617 |
| 8 | Supraventricular arrhythmia (HP:0005115) | 5.80144907 |
| 9 | Visual hallucinations (HP:0002367) | 5.63577837 |
| 10 | Heart block (HP:0012722) | 5.12363461 |
| 11 | Right ventricular cardiomyopathy (HP:0011663) | 5.04199338 |
| 12 | Ventricular arrhythmia (HP:0004308) | 4.84743772 |
| 13 | Lipoatrophy (HP:0100578) | 4.79553531 |
| 14 | Abnormal atrioventricular conduction (HP:0005150) | 4.77516797 |
| 15 | Hyporeflexia of lower limbs (HP:0002600) | 4.72829314 |
| 16 | Abnormality of the calf musculature (HP:0001430) | 4.50930041 |
| 17 | Focal seizures (HP:0007359) | 4.47464595 |
| 18 | Progressive cerebellar ataxia (HP:0002073) | 4.36797050 |
| 19 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.28406147 |
| 20 | Epileptic encephalopathy (HP:0200134) | 4.28335677 |
| 21 | Action tremor (HP:0002345) | 4.22361282 |
| 22 | Atonic seizures (HP:0010819) | 4.18794112 |
| 23 | Myokymia (HP:0002411) | 4.13096014 |
| 24 | Muscle fiber splitting (HP:0003555) | 4.08068858 |
| 25 | Dilated cardiomyopathy (HP:0001644) | 3.97446424 |
| 26 | Subaortic stenosis (HP:0001682) | 3.94580166 |
| 27 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.94580166 |
| 28 | Prolonged QT interval (HP:0001657) | 3.93434401 |
| 29 | Atrioventricular block (HP:0001678) | 3.92978907 |
| 30 | Absence seizures (HP:0002121) | 3.80971414 |
| 31 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.78048222 |
| 32 | Febrile seizures (HP:0002373) | 3.68809729 |
| 33 | Abnormal EKG (HP:0003115) | 3.66024326 |
| 34 | Asymmetric septal hypertrophy (HP:0001670) | 3.54529107 |
| 35 | Impaired smooth pursuit (HP:0007772) | 3.43480546 |
| 36 | Gaze-evoked nystagmus (HP:0000640) | 3.41709729 |
| 37 | EMG: neuropathic changes (HP:0003445) | 3.41530992 |
| 38 | Dialeptic seizures (HP:0011146) | 3.40130562 |
| 39 | Calf muscle hypertrophy (HP:0008981) | 3.31829499 |
| 40 | Truncal ataxia (HP:0002078) | 3.27083135 |
| 41 | Left ventricular hypertrophy (HP:0001712) | 3.25713825 |
| 42 | Agitation (HP:0000713) | 3.24221872 |
| 43 | Epileptiform EEG discharges (HP:0011182) | 3.22523030 |
| 44 | Generalized tonic-clonic seizures (HP:0002069) | 3.21792007 |
| 45 | EMG: myopathic abnormalities (HP:0003458) | 3.18765048 |
| 46 | EEG with generalized epileptiform discharges (HP:0011198) | 3.16717084 |
| 47 | Palpitations (HP:0001962) | 3.13721454 |
| 48 | Depression (HP:0000716) | 3.02328058 |
| 49 | Dysdiadochokinesis (HP:0002075) | 3.00939731 |
| 50 | Hypsarrhythmia (HP:0002521) | 2.99628096 |
| 51 | Hemiparesis (HP:0001269) | 2.99097030 |
| 52 | Papilledema (HP:0001085) | 2.98309944 |
| 53 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.97776783 |
| 54 | Hypoglycemic seizures (HP:0002173) | 2.97637552 |
| 55 | Supranuclear gaze palsy (HP:0000605) | 2.97603647 |
| 56 | Decreased circulating renin level (HP:0003351) | 2.97182521 |
| 57 | Broad-based gait (HP:0002136) | 2.94387192 |
| 58 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.86044154 |
| 59 | Anxiety (HP:0000739) | 2.77483715 |
| 60 | Poor eye contact (HP:0000817) | 2.71560161 |
| 61 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.71353956 |
| 62 | Dysmetria (HP:0001310) | 2.69683969 |
| 63 | Symptomatic seizures (HP:0011145) | 2.68536092 |
| 64 | Genetic anticipation (HP:0003743) | 2.68405142 |
| 65 | Diplopia (HP:0000651) | 2.64623742 |
| 66 | Abnormality of binocular vision (HP:0011514) | 2.64623742 |
| 67 | Scanning speech (HP:0002168) | 2.64433924 |
| 68 | Hyperventilation (HP:0002883) | 2.60440424 |
| 69 | Abnormality of the lower motor neuron (HP:0002366) | 2.60121271 |
| 70 | Intention tremor (HP:0002080) | 2.56507484 |
| 71 | Excessive salivation (HP:0003781) | 2.55888327 |
| 72 | Drooling (HP:0002307) | 2.55888327 |
| 73 | Distal lower limb muscle weakness (HP:0009053) | 2.54285656 |
| 74 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.52201907 |
| 75 | Abnormality of the foot musculature (HP:0001436) | 2.51418755 |
| 76 | Pheochromocytoma (HP:0002666) | 2.49506760 |
| 77 | Bradycardia (HP:0001662) | 2.48499929 |
| 78 | Abnormal social behavior (HP:0012433) | 2.47344232 |
| 79 | Impaired social interactions (HP:0000735) | 2.47344232 |
| 80 | Dysmetric saccades (HP:0000641) | 2.43313934 |
| 81 | Cerebral inclusion bodies (HP:0100314) | 2.39665913 |
| 82 | Congenital malformation of the right heart (HP:0011723) | 2.37617293 |
| 83 | Double outlet right ventricle (HP:0001719) | 2.37617293 |
| 84 | Hemiplegia (HP:0002301) | 2.36019613 |
| 85 | Sudden cardiac death (HP:0001645) | 2.35542165 |
| 86 | Neurofibrillary tangles (HP:0002185) | 2.30895049 |
| 87 | Increased circulating renin level (HP:0000848) | 2.30469363 |
| 88 | Postural tremor (HP:0002174) | 2.30120582 |
| 89 | Hypoplastic left heart (HP:0004383) | 2.26111041 |
| 90 | Amblyopia (HP:0000646) | 2.24238097 |
| 91 | Ragged-red muscle fibers (HP:0003200) | 2.23960747 |
| 92 | Ankle clonus (HP:0011448) | 2.23472868 |
| 93 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.22759934 |
| 94 | Ventricular fibrillation (HP:0001663) | 2.21580316 |
| 95 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.18839915 |
| 96 | Hyperglycemia (HP:0003074) | 2.18501786 |
| 97 | Postural instability (HP:0002172) | 2.17102053 |
| 98 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.17069400 |
| 99 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.16695855 |
| 100 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.16695855 |
| 101 | Ketoacidosis (HP:0001993) | 2.16519296 |
| 102 | Amyotrophic lateral sclerosis (HP:0007354) | 2.14184560 |
| 103 | Central scotoma (HP:0000603) | 2.13760051 |
| 104 | Foot dorsiflexor weakness (HP:0009027) | 2.13481517 |
| 105 | Large for gestational age (HP:0001520) | 2.13210250 |
| 106 | Steppage gait (HP:0003376) | 2.12351276 |
| 107 | Spastic gait (HP:0002064) | 2.08418881 |
| 108 | Neuroendocrine neoplasm (HP:0100634) | 2.07043533 |
| 109 | Abnormal eating behavior (HP:0100738) | 2.06827016 |
| 110 | Gait ataxia (HP:0002066) | 2.04836665 |
| 111 | Megalencephaly (HP:0001355) | 2.03778679 |
| 112 | Limb ataxia (HP:0002070) | 2.03575943 |
| 113 | Neck muscle weakness (HP:0000467) | 2.01743633 |
| 114 | Bradykinesia (HP:0002067) | 2.01737052 |
| 115 | Palmoplantar keratoderma (HP:0000982) | 2.01120914 |
| 116 | Retinal atrophy (HP:0001105) | 1.99706139 |
| 117 | Menstrual irregularities (HP:0000858) | 1.98293219 |
| 118 | Type 1 muscle fiber predominance (HP:0003803) | 1.97630803 |
| 119 | Bundle branch block (HP:0011710) | 1.97214779 |
| 120 | Abnormality of renin-angiotensin system (HP:0000847) | 1.93692371 |
| 121 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.93318974 |
| 122 | Absent speech (HP:0001344) | 1.92938059 |
| 123 | Abnormality of macular pigmentation (HP:0008002) | 1.91781988 |
| 124 | Restlessness (HP:0000711) | 1.90531848 |
| 125 | Hypoplastic heart (HP:0001961) | 1.88783187 |
| 126 | Blue irides (HP:0000635) | 1.87697506 |
| 127 | Mutism (HP:0002300) | 1.87462383 |
| 128 | Stereotypic behavior (HP:0000733) | 1.86693747 |
| 129 | Macroorchidism (HP:0000053) | 1.85715872 |
| 130 | Psychosis (HP:0000709) | 1.84995741 |
| 131 | Difficulty running (HP:0009046) | 1.83359675 |
| 132 | Areflexia of lower limbs (HP:0002522) | 1.83284650 |
| 133 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.82703261 |
| 134 | Obstructive sleep apnea (HP:0002870) | 1.82176627 |
| 135 | Type II lissencephaly (HP:0007260) | 1.82051129 |
| 136 | Status epilepticus (HP:0002133) | 1.80842509 |
| 137 | Tetraplegia (HP:0002445) | 1.79698091 |
| 138 | Gait imbalance (HP:0002141) | 1.78342392 |
| 139 | Myotonia (HP:0002486) | 1.77108046 |
| 140 | Neoplasm of the heart (HP:0100544) | 1.76021833 |
| 141 | Neuronal loss in central nervous system (HP:0002529) | 1.75557138 |
| 142 | Hypoglycemic coma (HP:0001325) | 1.74826770 |
| 143 | Rimmed vacuoles (HP:0003805) | 1.74256679 |
| 144 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.73571049 |
| 145 | Abnormality of the corticospinal tract (HP:0002492) | 1.73363962 |
| 146 | Hyperkalemia (HP:0002153) | 1.72407074 |
| 147 | Global brain atrophy (HP:0002283) | 1.71684103 |
| 148 | Clonus (HP:0002169) | 1.71636478 |
| 149 | Resting tremor (HP:0002322) | 1.71313649 |
| 150 | Anomalous pulmonary venous return (HP:0010772) | 1.71022512 |
| 151 | Lower limb muscle weakness (HP:0007340) | 1.70458342 |
| 152 | Limb dystonia (HP:0002451) | 1.69943722 |
| 153 | Failure to thrive in infancy (HP:0001531) | 1.69898617 |
| 154 | Slow progression (HP:0003677) | 1.69884845 |
| 155 | Hypokalemia (HP:0002900) | 1.69482469 |
| 156 | Periauricular skin pits (HP:0100277) | 1.68148405 |
| 157 | Preauricular pit (HP:0004467) | 1.68148405 |
| 158 | Lymphangioma (HP:0100764) | 1.68050739 |
| 159 | Congestive heart failure (HP:0001635) | 1.62128934 |
| 160 | Lower limb amyotrophy (HP:0007210) | 1.56725650 |
| 161 | Hip contracture (HP:0003273) | 1.54273822 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.64033325 |
| 2 | OBSCN | 3.69199863 |
| 3 | MYLK | 3.69002963 |
| 4 | DMPK | 3.34868213 |
| 5 | MAP3K9 | 3.00545841 |
| 6 | INSRR | 2.96001945 |
| 7 | PRKD3 | 2.85578169 |
| 8 | MAP3K4 | 2.82844850 |
| 9 | MARK1 | 2.79702171 |
| 10 | CAMKK2 | 2.57656948 |
| 11 | EPHA4 | 2.51508535 |
| 12 | MINK1 | 2.25186808 |
| 13 | TTN | 2.22998921 |
| 14 | MAP2K7 | 2.22598965 |
| 15 | MAP3K2 | 2.05927720 |
| 16 | CAMKK1 | 2.00544303 |
| 17 | DAPK2 | 1.94221104 |
| 18 | PAK6 | 1.84935767 |
| 19 | NTRK1 | 1.82869596 |
| 20 | MAP2K4 | 1.70119817 |
| 21 | PNCK | 1.66287376 |
| 22 | UHMK1 | 1.63285021 |
| 23 | NTRK2 | 1.63068366 |
| 24 | KSR2 | 1.62916859 |
| 25 | RIPK4 | 1.60424998 |
| 26 | PKN2 | 1.58306727 |
| 27 | CASK | 1.51737675 |
| 28 | WNK3 | 1.51192943 |
| 29 | STK38 | 1.47225065 |
| 30 | MAPK15 | 1.46442970 |
| 31 | MAPK12 | 1.45857829 |
| 32 | WNK1 | 1.39892662 |
| 33 | GRK7 | 1.39680859 |
| 34 | CDK5 | 1.38990112 |
| 35 | GRK5 | 1.38193650 |
| 36 | PRPF4B | 1.36224231 |
| 37 | PIK3CA | 1.35968506 |
| 38 | HIPK2 | 1.32793960 |
| 39 | PRKCG | 1.27634386 |
| 40 | LMTK2 | 1.25584228 |
| 41 | PRKCH | 1.23133003 |
| 42 | RIPK1 | 1.19614006 |
| 43 | SCYL2 | 1.16416670 |
| 44 | DAPK1 | 1.16057364 |
| 45 | CDC42BPA | 1.15896282 |
| 46 | KSR1 | 1.14539926 |
| 47 | FRK | 1.14328137 |
| 48 | TAOK3 | 1.13992461 |
| 49 | PLK2 | 1.13830601 |
| 50 | LATS2 | 1.13479261 |
| 51 | PRKD1 | 1.12048371 |
| 52 | ROCK1 | 1.07321278 |
| 53 | PASK | 1.07041630 |
| 54 | MAP3K1 | 1.06346241 |
| 55 | STK38L | 1.05716079 |
| 56 | MAPK13 | 1.05387496 |
| 57 | SGK494 | 1.02870342 |
| 58 | SGK223 | 1.02870342 |
| 59 | WNK4 | 1.00585611 |
| 60 | CAMK2B | 1.00229287 |
| 61 | MUSK | 0.98789800 |
| 62 | CAMK2A | 0.97931297 |
| 63 | RET | 0.97336601 |
| 64 | TNIK | 0.96732372 |
| 65 | ROCK2 | 0.95897284 |
| 66 | LIMK1 | 0.94961879 |
| 67 | DYRK1A | 0.94575412 |
| 68 | SGK2 | 0.93648335 |
| 69 | SIK2 | 0.91355136 |
| 70 | PAK3 | 0.88219104 |
| 71 | BMPR2 | 0.88170542 |
| 72 | AKT3 | 0.85865844 |
| 73 | PINK1 | 0.85440551 |
| 74 | PKN1 | 0.85433930 |
| 75 | CAMK2D | 0.84238681 |
| 76 | MAP3K12 | 0.83996186 |
| 77 | MAP3K7 | 0.82980130 |
| 78 | CAMK1 | 0.82631074 |
| 79 | FES | 0.80196853 |
| 80 | STK11 | 0.80065524 |
| 81 | CDK19 | 0.77739604 |
| 82 | SGK3 | 0.75681164 |
| 83 | CAMK1G | 0.75205692 |
| 84 | SGK1 | 0.72822105 |
| 85 | MAP3K5 | 0.72324236 |
| 86 | PHKG1 | 0.71858434 |
| 87 | PHKG2 | 0.71858434 |
| 88 | MARK2 | 0.71735278 |
| 89 | FER | 0.71529173 |
| 90 | TRPM7 | 0.69080492 |
| 91 | ARAF | 0.66590177 |
| 92 | PRKCE | 0.64916665 |
| 93 | CDK15 | 0.64727465 |
| 94 | PDK2 | 0.64253152 |
| 95 | CDK18 | 0.64230141 |
| 96 | CDK14 | 0.63473555 |
| 97 | ALK | 0.62382591 |
| 98 | PDK1 | 0.59981062 |
| 99 | PTK2B | 0.58905013 |
| 100 | MAPK7 | 0.58571756 |
| 101 | TYRO3 | 0.57344894 |
| 102 | PTK2 | 0.57321438 |
| 103 | PDGFRA | 0.56550782 |
| 104 | RPS6KA3 | 0.54729986 |
| 105 | CDK11A | 0.53852525 |
| 106 | PDPK1 | 0.52432687 |
| 107 | FGFR2 | 0.51102956 |
| 108 | PRKD2 | 0.50945132 |
| 109 | CAMK2G | 0.48780932 |
| 110 | MAP3K13 | 0.47489841 |
| 111 | MAPK4 | 0.46640209 |
| 112 | MAPK10 | 0.46446013 |
| 113 | PRKAA1 | 0.45998979 |
| 114 | DAPK3 | 0.45389375 |
| 115 | NEK6 | 0.45038463 |
| 116 | MAP3K6 | 0.43393106 |
| 117 | LATS1 | 0.43153123 |
| 118 | DDR2 | 0.42888647 |
| 119 | PRKG1 | 0.42813306 |
| 120 | CSNK1G2 | 0.42652785 |
| 121 | PRKACA | 0.41830350 |
| 122 | PRKAA2 | 0.39776088 |
| 123 | NEK9 | 0.39406619 |
| 124 | FYN | 0.38969477 |
| 125 | STK4 | 0.38606025 |
| 126 | PRKCZ | 0.38448313 |
| 127 | OXSR1 | 0.38194425 |
| 128 | PRKCB | 0.38014974 |
| 129 | PRKCA | 0.37573085 |
| 130 | CAMK4 | 0.37332346 |
| 131 | RPS6KB1 | 0.36289837 |
| 132 | PRKACG | 0.36208771 |
| 133 | MAP2K1 | 0.35856349 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.36946377 |
| 2 | Insulin secretion_Homo sapiens_hsa04911 | 2.90886420 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.82526827 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.79489296 |
| 5 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.78747508 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.64865370 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.60999804 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.53891143 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.47755779 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.47015025 |
| 11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.34744067 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.28633125 |
| 13 | Morphine addiction_Homo sapiens_hsa05032 | 2.24319636 |
| 14 | Taste transduction_Homo sapiens_hsa04742 | 2.12498930 |
| 15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.06928161 |
| 16 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.03343796 |
| 17 | Salivary secretion_Homo sapiens_hsa04970 | 1.95944834 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.93323579 |
| 19 | Olfactory transduction_Homo sapiens_hsa04740 | 1.89814627 |
| 20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.79801040 |
| 21 | Long-term depression_Homo sapiens_hsa04730 | 1.79235347 |
| 22 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.65563471 |
| 23 | Cocaine addiction_Homo sapiens_hsa05030 | 1.60439675 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.58682379 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.57643385 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.52227655 |
| 27 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.46366761 |
| 28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.42931525 |
| 29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.42337836 |
| 30 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.38903160 |
| 31 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.38685185 |
| 32 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.37545762 |
| 33 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.37226680 |
| 34 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.35819313 |
| 35 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.33386652 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.31947168 |
| 37 | Phototransduction_Homo sapiens_hsa04744 | 1.27914010 |
| 38 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.27259347 |
| 39 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.25765339 |
| 40 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.23526050 |
| 41 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.21974489 |
| 42 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.19290845 |
| 43 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.19210788 |
| 44 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.14125163 |
| 45 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.13962788 |
| 46 | Gap junction_Homo sapiens_hsa04540 | 1.13514938 |
| 47 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.12248324 |
| 48 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.06367094 |
| 49 | Circadian rhythm_Homo sapiens_hsa04710 | 1.04747141 |
| 50 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.00864793 |
| 51 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.96211193 |
| 52 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.88459658 |
| 53 | Melanogenesis_Homo sapiens_hsa04916 | 0.87453015 |
| 54 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.84824828 |
| 55 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.83124324 |
| 56 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.82606790 |
| 57 | Glioma_Homo sapiens_hsa05214 | 0.82262978 |
| 58 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.81123009 |
| 59 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.74959650 |
| 60 | Tight junction_Homo sapiens_hsa04530 | 0.74405069 |
| 61 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.72515549 |
| 62 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.70488214 |
| 63 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.69378323 |
| 64 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68358090 |
| 65 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.66886085 |
| 66 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.66128605 |
| 67 | Protein export_Homo sapiens_hsa03060 | 0.64617497 |
| 68 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64007214 |
| 69 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.63910969 |
| 70 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.63415639 |
| 71 | Axon guidance_Homo sapiens_hsa04360 | 0.61115300 |
| 72 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.58806574 |
| 73 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56901857 |
| 74 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.56778641 |
| 75 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.56329187 |
| 76 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55658970 |
| 77 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.54629241 |
| 78 | Focal adhesion_Homo sapiens_hsa04510 | 0.54586231 |
| 79 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.50583893 |
| 80 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50326108 |
| 81 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.49581912 |
| 82 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49273642 |
| 83 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.47537276 |
| 84 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.47236144 |
| 85 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.46985937 |
| 86 | Alcoholism_Homo sapiens_hsa05034 | 0.46763167 |
| 87 | Prion diseases_Homo sapiens_hsa05020 | 0.46645052 |
| 88 | Bile secretion_Homo sapiens_hsa04976 | 0.45552657 |
| 89 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44698463 |
| 90 | Adherens junction_Homo sapiens_hsa04520 | 0.43638834 |
| 91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43500946 |
| 92 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.43458418 |
| 93 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.43265401 |
| 94 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.42578402 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42028005 |
| 96 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.39413174 |
| 97 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39280213 |
| 98 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.38966444 |
| 99 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.37964867 |
| 100 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.37766196 |
| 101 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.34669884 |
| 102 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.34659673 |
| 103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34082992 |
| 104 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.33298820 |
| 105 | Endometrial cancer_Homo sapiens_hsa05213 | 0.33055090 |
| 106 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.32986428 |
| 107 | Insulin resistance_Homo sapiens_hsa04931 | 0.32946464 |
| 108 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.32839911 |
| 109 | Parkinsons disease_Homo sapiens_hsa05012 | 0.32836034 |
| 110 | Endocytosis_Homo sapiens_hsa04144 | 0.32545505 |
| 111 | Carbon metabolism_Homo sapiens_hsa01200 | 0.31765681 |
| 112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31348632 |
| 113 | Amoebiasis_Homo sapiens_hsa05146 | 0.30590767 |
| 114 | Lysosome_Homo sapiens_hsa04142 | 0.30261757 |
| 115 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.29440800 |
| 116 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.29113485 |
| 117 | Alzheimers disease_Homo sapiens_hsa05010 | 0.29076658 |
| 118 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.28855717 |
| 119 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.28347204 |
| 120 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.27327095 |
| 121 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.27292252 |
| 122 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.27253492 |
| 123 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.27051744 |
| 124 | Mineral absorption_Homo sapiens_hsa04978 | 0.26819240 |

